New listings in AVMA Animal Health Studies Database – August 2022

Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database. Information about participation in the studies is available at the database site.

AAHSD005469: “Rapamycin in cats with chronic kidney disease,” The Ohio State University.

AAHSD005471: “A multi-center pivotal study to determine the effectiveness and safety of an investigational veterinary product for the treatment of lymphoma in dogs,” Quakertown Veterinary Clinic, Quakertown, Pennsylvania; Franklin Animal Clinic, Franklin, Indiana; MedVet Akron, Akron, Ohio; Manley Animal Hospital, Bartelsville, Oklahoma; BluePearl Pet Hospital, Malvern, Pennsylvania; MedVet Dallas, Dallas; MedVet Salt Lake City; and the University of Wisconsin-Madison.

AAHSD005472: “Pilot safety and effectiveness study of a novel stem cell therapy preparation in client-owned cats with chronic kidney disease (CKD),” Friendship Hospital for Animals, Washington, D.C., and Quakertown Veterinary Clinic, Quakertown, Pennsylvania.

AAHSD005487: “Phase I clinical trial of NCGC00413972 (NIH 972) in dogs with spontaneously occurring sarcomas,” Colorado State University.

AAHSD005507: “ADAMTS13 activity in dogs with presumptive idiopathic immune thrombocytopenia,” Virginia-Maryland College of Veterinary Medicine.

AAHSD005508: “Thromboelastography in cats with hypertrophic cardiomyopathy,” Virginia-Maryland College of Veterinary Medicine.